CAOYF yields 967.35% · PFE yields 6.13%● Live data
📍 CAOYF pulled ahead of the other in Year 1
Combined, CAOYF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CAOYF + PFE for your $10,000?
China Aoyuan Group Limited engages in the development of commercial real estate properties in Mainland China, Hong Kong, Australia, and Canada. The company operates through Property Development, Property Investment, and Others segments. It also acquires and develops various real estate projects; and develops and operates cultural tourism, hotel management, sports development, and resort projects. In addition, the company imports and export goods, such as maternal and child care products, cosmetics and skin care products, clothing and bags, food and beverages, household goods, and parallel imported vehicles. Further, it provides medical service platform combining online and offline services; consultancy services; construction services; and financing services. The company was formerly known as China Aoyuan Property Group Limited and changed its name to China Aoyuan Group Limited in November 2018. China Aoyuan Group Limited was founded in 1996 and is based in Guangzhou, the People's Republic of China. China Aoyuan Group Limited operates as a subsidiary of Ace Rise Profits Limited.
Full CAOYF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.